Clinical Trial: Evaluation of a CD4/CD8+ Interferon Gamma Release Assay for Monitoring Anti-Tuberculosis Treatment
Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Condition: Tuberculosis
Study Type: Observational
Official Title: Evaluation of a CD4/CD8+ Interferon Gamma Release Assay for Monitoring Anti-Tuberculosis Treatment
Brief Summary:
Evaluate the possibility of using an IGRA (Interferon-? Release Assay) test for monitoring the response to anti-tuberculosis therapy by studying the correlation between the variation in the Interferon-gamma (IFN-?) response to the QFT-Plus test in the two tubes containing antigens and the gold standard for monitoring TB therapy (culture conversion) in patients with slide positive/culture positive and slide negative/culture positive PTB.Evaluate the level of agreement between the results of the new QFT Access test…
Read more